CFLAR and myocarditis: In c-FLIPL-transgenic mice infected with coxsackievirus B3 (CVB3), c-FLIPL expression in T cells augments cell survival pathways and T-cell receptor (TCR) signaling, thus lowering the severity of CVB3-induced myocarditis [167].